NEWA Skin Care Device review

Across every device on this site - LED masks, microcurrent, IPL, RF - we found exactly one De Novo authorization, and it belongs to NEWA.

A 510(k) clearance, which almost everything else here holds, demonstrates substantial equivalence to a device already legally on the market. The argument is comparative. A De Novo is used when a device is low-to-moderate risk but genuinely novel, with no predicate to compare against. The FDA evaluates safety and effectiveness directly and, if satisfied, creates a new classification.

DEN150005, granted 18 December 2015 to EndyMed Medical Ltd. There is also an earlier 510(k), K130793, from August 2013 under Endymion Medical. What the routes mean.

Multi-source radiofrequency, with a published treatment protocol: an intensive phase followed by maintenance. A dedicated RF gel is required.

What NEWA does not publish is a target skin temperature. TriPollar publishes up to 41.6 C and measures against it with a thermal sensor; NEWA publishes a schedule instead.

That is a genuine gap. Temperature is the governing variable in RF, and a device that does not state its target leaves you judging by sensation.

Quick picks

The short answer

#	Product	Best for	FDA clearance	Price
1	NEWA Skin Care Device Strongest regulatory record on this site	anyone who weights an FDA evaluation above a spec sheet	Located	Check price on Amazon #ad How we are funded

Prices are checked live and stamped with the date they were read. No live price is held for these listings right now, so every button reads “Check price on Amazon” rather than showing a number we cannot stand behind. Last price check: October 13, 2026.

NEWA specifies a defined intensive phase followed by ongoing maintenance, rather than the vague use regularly that several brands offer.

In a category where adherence decides outcomes, a manufacturer that tells you exactly what the course is has done something useful. It is also consistent with the De Novo: a device assessed on its effectiveness has a protocol that was part of that assessment.

The De Novo is from 2015 and the device's industrial design shows it against newer rivals. Two readings of that:

• Positive: a decade of market presence, a long safety record and a classification that still stands.
• Negative: no thermal sensing, no muscle-activation layer, and none of the refinements that newer devices have added.

Both are true. Which matters more depends on whether you are buying evidence or features.

• No published target temperature, the main specification gap.
• No thermal-mapping sensor.
• No muscle-activation mechanism, so it is a single-mechanism RF device.
• A dedicated gel requirement, as with all RF.
• Older design. Cosmetic, but noticeable alongside current devices.

In detail

Every pick, and why

Illustrative photograph. Not a picture of this model.

Check price on Amazon

#ad How we are funded

Strongest regulatory record on this site

NEWA Skin Care Device

NEWA (EndyMed) · Best for anyone who weights an FDA evaluation above a spec sheet

De Novo DEN150005, granted 18 December 2015 to EndyMed Medical, plus an earlier 510(k) (K130793). Multi-source RF with a defined published protocol. No target temperature published, and the industrial design is of its era.

The home RF device with the strongest regulatory paper trail here: a De Novo authorization rather than a substantial-equivalence clearance.

Specifications

Technology	Multi-source radiofrequency
Protocol	Intensive phase then maintenance; manufacturer publishes a defined schedule
Regulatory route	De Novo DEN150005, which created the classification rather than matching one

FDA clearance located

De Novo DEN150005 (NEWA Skin Therapy System, 18 December 2015, EndyMed Medical Ltd.), with an earlier 510(k) K130793 (16 August 2013). Product codes PAY and GEI.

What works

• A De Novo authorization is a stronger regulatory signal than a 510(k) and almost nobody here has one
• Published, defined treatment schedule
• Long track record

What does not

• Older industrial design than the TriPollar line
• Requires its own gel
• No muscle-activation mechanism

Specifications from FDA De Novo DEN150005; 510(k) K130793, checked 13 October 2026.

• Anyone who wants published thermal control. The TriPollar VX2 is the device for that.
• Anyone who wants muscle activation as well as RF.
• Anyone with an implanted electrical device. RF is contraindicated.
• Anyone with melasma, because heat is a trigger.
• Anyone whose complaint is texture or tone, which is LED territory.

We would still rather own a device whose effectiveness someone actually evaluated than one with a longer feature list, and that is why the NEWA sits where it does in our RF roundup.